ADCY1 and melanoma: For example, Ma et al. (23) demonstrated that miR-23a-3p mitigated mucosal melanoma growth, migration, invasion, and tumorigenicity by targeting ADCY1 via the suppression of cAMP and MAPK signaling pathways.